Posts

KIMM develops wheel that alters stiffness in real time ...

A new technology for wheels and mobile systems, necessary for overcoming various...

Open Wide: Human Mouth Bacteria Reproduce through Rare ...

By Emily Greenhalgh Credit: Scott Chimileski, Marine Biological Laboratory. See ...

The nervous system’s matchmaker

When you ask a rideshare app to find you a car, the company’s computers get to w...

Exploring peptide clumping for improved drug and materi...

Scientists from China have investigated how short peptide chains aggregate toget...

Can’t stop belching? Dietary habits or disease could be...

Belching is a common bodily function, but when it escalates to a level that inte...

Allist Secures Leading Role in China’s KRAS Inhibitor M...

Shanghai Allist Pharmaceuticals has significantly bolstered its position in Chin...

Emergent Bio’s Smallpox Vaccine Gains FDA Approval for ...

Emergent BioSolutions’ smallpox vaccine has received expanded approval from the ...

ESC 2024: CATHEDRAL-HF trial results have the potential...

A large proportion of chronic heart failure (HF) patients are taking suboptimal ...

Diabetes duration has minimal impact on SGLT2 inhibitor...

A meta-analysis has demonstrated consistent efficacy in heart failure outcomes w...

ESC 2024: Study highlights potential for Novartis to di...

There is a strong opportunity in the heart failure (HF) space for new agents tha...

Singapore scientists to use exosomes secreted by living...

Singapore, 2 September 2024 – In a new study, clinician-scientists and researche...

Siemens Healthineers to Acquire Novartis’ European Radi...

As part of its strategy to expand PET imaging capabilities, Siemens Healthineers...

Generalized Pustular Psoriasis (GPP) drugs in developme...

GlobalData tracks 6 drugs in development for Generalized Pustular Psoriasis (GPP...

Frontotemporal Dementia (FTD) drugs in development, 2024

GlobalData tracks 119 drugs in development for Frontotemporal Dementia (FTD) by ...

Aromatic l-Amino Acid Decarboxylase (AADC) Deficiency d...

GlobalData tracks 6 drugs in development for Aromatic l-Amino Acid Decarboxylase...

ESC 2024: Latest FLOW trial analysis highlights how Oze...

If approved, Novo Nordisk's Ozempic will become the first GLP-1 therapy option f...